Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
TDOC US​

Teladoc Health, Inc.(TDOC US)

$6.34+0.020.32%Ext:$6.27-0.071.16%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Teladoc Health, Inc. — Company Profile

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Sector
Consumer Staples
Industry
Personal Care Products
Exchange
UN
CEO
Charles Divita
Headquarters
New York, NY, US
IPO Date
Jun 30, 2015
Employees
5,124
Website
www.teladochealth.com

Key Metrics

Price
$5.52
Market Cap
$1.00B
Revenue (TTM)
$613.85M
Net Income (TTM)
$-63837000.00
EPS (TTM)
-0.36
P/E (TTM)
-5.86
P/B (TTM)
0.75
Dividend Yield
0.00%
ROE (TTM)
-4.78%
ROA (TTM)
-2.27%
Operating Margin
-7.94%
Beta
0.89

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Website
www.teladochealth.com
Location
New York, NY, US
Phone203 635 2002
Employees5,124
CEOCharles Divita
Sector
Consumer Staples
Industry
Personal Care Products
IPO DateJun 30, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(1.6K)

Expand
  • SC 13GTeladoc Health, Inc.8 Oct
  • 4Statement of changes in beneficial ownership5 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers25 Sep
  • 4Statement of changes in beneficial ownership14 Sep
  • 144DIVITA CHARLES III11 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 4Statement of changes in beneficial ownership3 Sep
  • 144Rodrigues Fernando M.3 Sep
  • 144Bliss Kelly2 Sep
  • 144Rodrigues Fernando M.2 Sep
  • 144Vandervoort Adam C2 Sep
  • 144Nueno Carlos2 Sep
  • 144DIVITA CHARLES III2 Sep
  • 4Statement of changes in beneficial ownership1 Sep
  • 3Initial statement of beneficial ownership1 Sep
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers31 Aug

News

  • Teladoc (TDOC) Outperforms Broader Market: What You Need to Know19 Oct
  • Teladoc Health, Inc. $TDOC Shares Acquired by Counterpoint Mutual Funds LLC18 Oct
  • Teladoc Health to Announce Third Quarter 2026 Financial Results14 Oct
  • Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts13 Oct
  • Analyzing Teladoc Health (NYSE:TDOC) & Schrodinger (NASDAQ:SDGR)12 Oct
  • Teladoc Strengthens Solo Platform With New AI-Powered Care Tools8 Oct
  • Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know7 Oct
  • Stock Picks From Seeking Alpha's September 2026 New Analysts7 Oct
  • Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery7 Oct
  • Head to Head Survey: National Research (NASDAQ:NRC) vs. Teladoc Health (NYSE:TDOC)5 Oct
  • Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know29 Sep
  • 171,447 Teladoc Health, Inc. $TDOC Shares Sold by Corient Private Wealth LP28 Sep
  • Teladoc Health Announces Chief Legal Officer Transition25 Sep
  • Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note23 Sep
  • Teladoc (TDOC) Stock Slides as Market Rises: Facts to Know Before You Trade17 Sep
  • Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life12 Sep
  • Why Teladoc (TDOC) Outpaced the Stock Market Today11 Sep
  • Dow, Nasdaq Down Triple Digits as Brent Crude Tops July Peak9 Sep
  • 2 Beaten-Down Stocks to Avoid Right Now8 Sep
  • Here's Why Teladoc's Integrated Care Business Deserves More Attention7 Sep

Mentions in Filings

  • **Exhibit 99.1** **POMDOCTOR LIMITED Highlights Differentiated “Hardware + AI + Payment” Healthcare Infrastructure Model** GUANGZHOU, China, September 24, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today highlighted its differentiated “hardware + AI + payment” infrastructure model. The Company believes this integrated app …
    POMDOCTOR LtdTeladoc Health, Inc.·EX-99.1 - 6-K - PRESS RELEASE - POMDOCTOR LIMITED HIGHLIGHTS DIFFERENTIATED "HARDWARE + AI + PAYMENT" HEALTHCARE INFRASTRUCTURE MODEL·Q3 26·24 Sep
  • … lytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health, Inc.</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire Software, Inc. (NYSE: GWRE) …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1/A - Registration statement (general form, amendment)·Q3 26·14 Sep
  • … Analytics from 2007 to 2016. Before joining Verisk, Mr. Anquillare worked at Prudential Financial, focusing on life insurance and property and casualty operations. Since 2026, Mr. Anquillare has served on the board of <strong>Teladoc Health</strong> (NYSE: TDOC), a leading virtual care provider, where he also serves on the audit and compensation committees. Since 2024, Mr. Anquillare has served on the board of directors of Guidewire (NYSE: GWRE), a leading platfo …
    Bamboo Insurance Services, Inc.Teladoc Health, Inc.·S-1 - Registration statement (general form)·Q3 26·28 Aug
  • … esident, Chief Accounting Officer and Interim Chief Financial Officer October 2020 – SVP, Global Corporate Controller and Chief Accounting Officer, Wiley June 2020 – SVP, Chief Accounting Officer and Controller, <strong>Teladoc Health, Inc.</strong> March 2017 – SVP, Chief Accounting Officer and Controller, Wiley Jessica Kowalski 45 May 2026 Executive Vice President and General Manager, Research January 2022 – General Manager of Consulting and Customer S …
    JOHN WILEY & SONS, INC.Teladoc Health, Inc.·ARS - Annual report to security holders·FY26·13 Aug
  • #\*Teladoc Health, Inc. 61,444 334,870 Teleflex, Inc. 10,874 1,134,919
    Dimensional ETF TrustTeladoc Health, Inc.·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … currently face competition from a range of digital health companies, including direct competition from competitors offering cardiometabolic programs, such as Hello Heart Inc., Lark Technologies, Inc., Livongo (via <strong>Teladoc Health, Inc.</strong>), Vida Health, Inc., and Virta Health Corp.; competitors offering only MSK programs, such as Hinge Health, Inc.; and those that offer both cardiometabolic and MSK programs, such as SWORD Health, Inc. and DarioHealt …
    Omada Health, Inc.Teladoc Health, Inc.·10-Q - Quarterly report Q2·Q2 26·7 Aug

Key Stats

Trading

Px/Chg 1D$5.52 / -2.65%
Avg Volume5.10M
Beta0.89
Mkt Cap1.00B
FD Mkt Cap1.16B

Float

Shrs Out/Float181.68M / 180.51M
Short Float0.16%
Days to Cover5.72
Stock Repurchased$0.00

Current Valuation

EV1.29B
EV/EBITDA22.51
EV/Sales0.51
P/B0.75
P/S0.40
FCF Yield0.78%
ROE-4.78%
ROA-2.27%
Current Ratio2.80

Estimates

P/E-5.86
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-13.75-0.32-9.81-1.22-41.70-15.71
Price / Sales1.281.820.830.481.631.63
Price / Book Value1.031.890.930.820.760.75
Price / Free Cash Flow36.1525.2911.164.3412.32127.66
ENTERPRISE VALUE METRICS
Enterprise Value2,356.05,039.42,630.31,512.61,307.61,290.2
Enterprise Value / Sales1.572.091.010.592.042.10
Enterprise Value / EBITDA-100.34-668.6260.3147.6825.5833.33
Enterprise Value / EBIT-22.36-23.17-12.50-7.24-45.61-23.26

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue5.6%2,032.72,406.82,602.42,569.62,530.0
Gross Income6.2%1,382.41,662.91,842.41,818.31,758.4
EBITDA—-31.4-7.543.631.7147.3
EBIT-2.5%-239.0-217.5-210.5-208.8-215.8
Net Income-17.3%-428.8-13,659.5-220.4-1,001.2-200.3
EPS (Diluted)-19.6%-2.73-84.60-1.34-5.87-1.14
BALANCE SHEET
Cash & ST Inv-3.4%896.0918.21,123.71,298.3781.1
Total Assets-35.3%17,734.64,701.04,392.43,516.53,100.8
Total Liabilities38.6%1,688.92,393.22,066.32,025.41,715.1
Total Shareholder Equity-45.8%16,045.82,307.72,326.11,491.11,385.7
CASH FLOW
Net Operating Cash Flow11%194.0189.3350.0293.7294.4
Cap Ex1%-8.5-16.5-156.3-10.8-8.9
Free Cash Flow11.4%185.5172.8193.7282.9285.5

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)6.36
Basic Shares181.68
Market Cap1,154.6
Diluted Shares179.12
Fully Diluted Shares Outstanding179.12
Fully Diluted Market Cap1,138.3
+Consolidated Debt1,038.1
−In-the-Money Convertible Debt—
+Capital Leases42.2
+Operating Leases—
−Cash & Equivalents-750.7
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value1,441.9

Segment data

Revenue

by Products and services

  • Other100%

Revenue

by Geography

  • United States82%
  • Non-us18%

Related companies

HCA Healthcare, Inc.

HCA US

Tenet Healthcare Corp

THC US

Universal Health Services Inc

UHS US

Hims & Hers Health, Inc.

HIMS US

Surgery Partners, Inc.

SGRY US

Community Health Systems Inc

CYH US

Auna S.a.

AUNA US

PHYHEALTH Corp

OSCI US

Basel Medical Group Ltd

BMGL US

Rennova Health, Inc.

RNVA US

Cardiff Lexington Corp

CDIX US